WO2000018212A8 - Platelet-derived growth factor c, dna coding therefor, and uses thereof - Google Patents
Platelet-derived growth factor c, dna coding therefor, and uses thereofInfo
- Publication number
- WO2000018212A8 WO2000018212A8 PCT/US1999/022668 US9922668W WO0018212A8 WO 2000018212 A8 WO2000018212 A8 WO 2000018212A8 US 9922668 W US9922668 W US 9922668W WO 0018212 A8 WO0018212 A8 WO 0018212A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- platelet
- growth factor
- derived growth
- dna coding
- coding therefor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99952989A EP1123408A1 (en) | 1998-09-30 | 1999-09-30 | Platelet-derived growth factor c, dna coding therefor, and uses thereof |
AU65029/99A AU6502999A (en) | 1998-09-30 | 1999-09-30 | Platelet-derived growth factor c, dna coding therefor, and uses thereof |
CA002344561A CA2344561A1 (en) | 1998-09-30 | 1999-09-30 | Platelet-derived growth factor c, dna coding therefor, and uses thereof |
JP2000571742A JP2002525086A (en) | 1998-09-30 | 1999-09-30 | Platelet-derived growth factor C, DNA encoding the same, and use thereof |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10246198P | 1998-09-30 | 1998-09-30 | |
US60/102,461 | 1998-09-30 | ||
US10810998P | 1998-11-12 | 1998-11-12 | |
US60/108,109 | 1998-11-12 | ||
US11074998P | 1998-12-03 | 1998-12-03 | |
US60/110,749 | 1998-12-03 | ||
US11300298P | 1998-12-18 | 1998-12-18 | |
US60/113,002 | 1998-12-18 | ||
US13542699P | 1999-05-21 | 1999-05-21 | |
US60/135,426 | 1999-05-21 | ||
US14402299P | 1999-07-15 | 1999-07-15 | |
US60/144,022 | 1999-07-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000018212A2 WO2000018212A2 (en) | 2000-04-06 |
WO2000018212A9 WO2000018212A9 (en) | 2000-09-08 |
WO2000018212A8 true WO2000018212A8 (en) | 2007-11-22 |
Family
ID=27557649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/022668 WO2000018212A2 (en) | 1998-09-30 | 1999-09-30 | Platelet-derived growth factor c, dna coding therefor, and uses thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1123408A1 (en) |
JP (1) | JP2002525086A (en) |
CN (1) | CN1330664A (en) |
CA (1) | CA2344561A1 (en) |
WO (1) | WO2000018212A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE405651T1 (en) | 1998-03-17 | 2008-09-15 | Genentech Inc | POLYPEPTIDES HOMOLOGUE TO VEGF AND BMP1 |
EP1137773B1 (en) * | 1998-12-07 | 2008-08-13 | ZymoGenetics, Inc. | Growth factor homolog zvegf3 |
US6432673B1 (en) | 1998-12-07 | 2002-08-13 | Zymogenetics, Inc. | Growth factor homolog ZVEGF3 |
WO2000059940A2 (en) * | 1999-04-06 | 2000-10-12 | Eli Lilly And Company | Platelet-derived growth factor related gene and protein |
US6893637B1 (en) | 1999-10-21 | 2005-05-17 | Zymogenetics, Inc. | Method of treating fibrosis |
EP1335024A4 (en) * | 2000-10-19 | 2004-09-01 | Kyowa Hakko Kogyo Kk | Antibody inhibiting vplf activity |
CA2439612A1 (en) | 2001-03-09 | 2002-09-19 | Janssen Pharmaceutica N.V. | Modulation of smooth muscle cell proliferation |
US20060104978A1 (en) * | 2003-10-24 | 2006-05-18 | Ludwig Institute For Cancer Research | Methods and compositions for PDGF-C activation and inhibition |
US20060024302A1 (en) | 2004-03-05 | 2006-02-02 | Ludwig Institute For Cancer Research | Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same |
WO2005092921A2 (en) * | 2004-03-22 | 2005-10-06 | Eli Lilly And Company | Placental growth factor splice variants and their uses |
DE602006020881D1 (en) | 2005-08-15 | 2011-05-05 | Vegenics Pty Ltd | ENEN FEATURES |
ES2497641T3 (en) | 2006-05-17 | 2014-09-23 | The Ludwig Institute For Cancer Research | Direction to the regulation of VEGF-B of fatty acid transporters to modulate human diseases |
CN101392026B (en) * | 2008-10-09 | 2011-11-09 | 黄岚 | Polypeptide for preventing and treating fibrotic disease and liver cancer |
BR112014025560A2 (en) | 2012-04-24 | 2017-07-04 | Thrombogenics Nv | anti-pdgf-c antibodies |
CN104744565A (en) * | 2015-04-06 | 2015-07-01 | 苏州普罗达生物科技有限公司 | Antagonistic polypeptide for vascular endothelial growth factor C and application of antagonistic polypeptides |
CN104693285A (en) * | 2015-04-06 | 2015-06-10 | 苏州普罗达生物科技有限公司 | Vascular-endothelial-growth-factor-C antagonistic polypeptide and application thereof |
CN104693286A (en) * | 2015-04-06 | 2015-06-10 | 苏州普罗达生物科技有限公司 | Vascular endothelial growth factor C antagonistic polypeptide and application thereof |
CN105175546A (en) * | 2015-05-27 | 2015-12-23 | 连祺周 | Fusion protein of human vascular endothelial growth factor and epidermal growth factor-like domain 7 |
AU2017290762A1 (en) | 2016-07-01 | 2019-01-31 | Paracrine Therapeutics Ab | Methods and compositions for PDGF-CC inhibition |
-
1999
- 1999-09-30 WO PCT/US1999/022668 patent/WO2000018212A2/en not_active Application Discontinuation
- 1999-09-30 CN CN99811565A patent/CN1330664A/en active Pending
- 1999-09-30 CA CA002344561A patent/CA2344561A1/en not_active Abandoned
- 1999-09-30 EP EP99952989A patent/EP1123408A1/en not_active Withdrawn
- 1999-09-30 JP JP2000571742A patent/JP2002525086A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2000018212A9 (en) | 2000-09-08 |
EP1123408A1 (en) | 2001-08-16 |
WO2000018212A2 (en) | 2000-04-06 |
JP2002525086A (en) | 2002-08-13 |
CN1330664A (en) | 2002-01-09 |
CA2344561A1 (en) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000018212A8 (en) | Platelet-derived growth factor c, dna coding therefor, and uses thereof | |
AU3274995A (en) | Fibrin-binding peptides, dna coding therefor and uses thereof | |
AU4859797A (en) | Nanoparticles biosensor | |
AU6325599A (en) | New compounds, their preparation and use | |
AU6325899A (en) | New compounds, their preparation and use | |
AU6190199A (en) | New compounds, their preparation and use | |
AU6325799A (en) | New compounds, their preparation and use | |
AU6190299A (en) | New compounds, their preparation and use | |
AU6325699A (en) | New compounds, their preparation and use | |
AU5850798A (en) | Polynucleotides encoding proexendin, and methods and uses thereof | |
AU4568799A (en) | Biosensor | |
AU2326899A (en) | Reduced malto-oligosaccharides | |
AU3595099A (en) | New compounds, their preparation and use | |
AU6635800A (en) | Pyridomorphinans, thienomoprhinans and use thereof | |
AU2462399A (en) | Cubilin protein, dna sequences encoding cubilin and uses thereof | |
AU8586198A (en) | Growth differentiation factor, lefty-1 | |
AU3830799A (en) | Molecular rod and uses | |
AU3670395A (en) | Hippocampus-associated proteins, dna sequences coding therefor and uses thereof | |
AU5176299A (en) | Compound, composition and use | |
AU5491599A (en) | Irak3 polypeptides, polynucleotides and methods | |
AU1772299A (en) | Well treatment with microorganisms | |
AU4046599A (en) | Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof | |
AU9263598A (en) | New tissue-specific calpaines, their production and their use | |
AU2964899A (en) | 2,4-dioxo-5-arylidenimino-1,3-pyrimidines | |
AUPP617598A0 (en) | Genetic sequence and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99811565.7 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 1999 65029 Country of ref document: AU Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AU BA BB BG BR CA CN CU CZ EE GD HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AU BA BB BG BR CA CN CU CZ EE GD HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-63, DESCRIPTION, REPLACED BY NEW PAGES 1-63; PAGES 64-74, CLAIMS, REPLACED BY NEW PAGES 64-74; PAGES 1/31-31/31, DRAWINGS, REPLACED BY NEW PAGES 1/36-36/36; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 65029/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 510789 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2344561 Country of ref document: CA Ref document number: 2344561 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2000 571742 Country of ref document: JP Kind code of ref document: A |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999952989 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999952989 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999952989 Country of ref document: EP |